Erosive Esophagitis
📧 Sign up to get email alerts when something new happens for Erosive Esophagitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-11-23FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Omeprazole from Sandoz Inc, granting approval for this generic proton pump inhibitor under an AN…
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: Esomeprazole for Treatment of GERD in Pediatric Patients [Phase 4]
Phase 4 trial update on esomeprazole for treating gastroesophageal reflux disease and associated esophagitis in pediatric patients has compl…
-
FDA approval · 2010-11-17FDA Approved: OMEPRAZOLE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for the generic omeprazole from Lannett Company, Inc., authorizing continued marketing under the…
-
FDA approval · 2010-10-29FDA Approved: FAMOTIDINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
The FDA approved a supplemental application for famotidine from Dr. Reddy's Laboratories Limited, authorizing a modification to an existing …
-
CLINICAL_TRIALS trial_result · 2010-09-24Clinical Trial Update: Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders (PULS)
A completed clinical trial (PULS) assessed the efficacy of pantoprazole in patients older than 12 with reflux-associated sleep disorders, in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-09-16Clinical Trial Update: Efficacy of Pantoprazole in Patients Older Than 12 Years Who Have Symptoms of Non-Erosive Reflux Disease (NERD) or Erosive Gastroesophageal Reflux Disease (eGERD)
Completed clinical trial assessing the efficacy of pantoprazole in patients over 12 with non-erosive reflux disease or erosive GERD.
-
FDA approval · 2010-09-03FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for Protonix Delayed-Release (pantoprazole sodium) from Wyeth Pharmaceuticals LLC (a Pfizer subs…
-
FDA approval · 2010-09-03FDA Approved: DEXILANT — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Dexilant (dexlansoprazole) filed by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2010-09-03FDA Approved: ACIPHEX — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for ACIPHEX (rabeprazole sodium) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2010-09-03FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
The FDA approved Oceanside Pharmaceuticals' supplemental application for Omeprazole and Sodium Bicarbonate.
-
FDA approval · 2010-09-03FDA Approved: PRILOSEC — Supplemental Application (Covis Pharma US, Inc)
FDA approved a supplemental application for Prilosec (omeprazole magnesium) submitted by Covis Pharma US, Inc., representing a labeling amen…
-
CLINICAL_TRIALS trial_result · 2010-08-23Clinical Trial Update: Proton Pump Inhibitor (PPI) Therapy for Newly Diagnosed Esophagitis
A completed clinical trial update evaluates proton pump inhibitor therapy for patients newly diagnosed with esophagitis, including erosive e…
-
CLINICAL_TRIALS trial_result · 2010-07-21Clinical Trial Update: Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive Esophagitis [Phase 2]
Phase 2 trial comparing intravenous versus oral lansoprazole in patients with erosive esophagitis and gastroesophageal reflux disease to eva…
-
FDA label_change · 2010-07-16FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
The FDA approved a labeling supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole) from AmerisourceBergen. The update m…
-
FDA approval · 2010-07-15FDA Approved: FAMOTIDINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for famotidine from Alembic Pharmaceuticals Inc., adding approved changes to the product under the A…
-
FDA approval · 2010-07-15FDA Approved: FAMOTIDINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's supplemental application for famotidine.
-
FDA approval · 2010-06-29FDA Approved: FAMOTIDINE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' original application for famotidine, a generic H2 blocker used for ulcers and GERD indications.
-
FDA approval · 2010-05-27FDA Approved: FAMOTIDINE — Original Application (Navinta LLC)
FDA approves Navinta LLC's original application for famotidine. This approval permits a generic version of famotidine to enter the market.
-
FDA approval · 2010-04-30FDA Approved: RANITIDINE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for ranitidine from Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2010-03-04FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Nexium (esomeprazole magnesium) submitted by AstraZeneca Pharmaceuticals LP. The approval update…
-
FDA approval · 2010-01-20FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application to update the labeling for Omeprazole and Sodium Bicarbonate (Oceanside Pharmaceuticals).
-
FDA approval · 2009-11-18FDA Approved: NIZATIDINE — Original Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal's nizatidine original application (generic) for use in conditions treated by H2 blockers.
-
FDA approval · 2009-11-10FDA Approved: LANSOPRAZOLE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved an original ANDA for lansoprazole from Teva Pharmaceuticals USA, Inc., allowing a generic version of the proton pump inhibitor.…
-
FDA approval · 2009-11-10FDA Approved: LANSOPRAZOLE — Original Application (Mylan Pharmaceuticals Inc.)
The FDA approved Mylan Pharmaceuticals Inc.'s Original Application for a generic lansoprazole (Lansoprazole) under ANDA090763. Lansoprazole …
-
FDA approval · 2009-09-21FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
The FDA approved a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole). This action typically updates labeling, manu…